Patrys Ltd (PAB)

Currency in AUD
0.0230
0.0000(0.00%)
Closed·
PAB is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.02300.0230
52 wk Range
0.02000.0520
Key Statistics
Bid/Ask
0.023 / 0.023
Prev. Close
0.023
Open
0.023
Day's Range
0.023-0.023
52 wk Range
0.02-0.052
Volume
102.99K
Average Volume (3m)
354.61K
1-Year Change
-37.8378%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
PAB Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Neutral
Moving Averages
Strong Sell

Earnings

Latest Release
Aug 31, 2026
EPS / Forecast
-- / --
Revenue / Forecast
6.69K / --
EPS Revisions
Last 90 days

PAB Income Statement

Compare PAB to Peers and Sector

Metrics to compare
PAB
Peers
Sector
Relationship
P/E Ratio
−3.9x−3.0x−0.2x
PEG Ratio
−0.060.000.00
Price/Book
1.4x1.8x2.6x
Price / LTM Sales
1,490.4x13.3x2.7x
Upside (Analyst Target)
-430.3%68.5%
Fair Value Upside
Unlock−6.3%11.5%Unlock

Patrys Limited, together with its subsidiaries, develops antibody technologies for the treatment of cancer and inflammatory diseases. The Company’s portfolio includes an injectable quetiapine program for the treatment of delirium and its versatile deoxymab antibody platform, including PAT-DX1 and PAT-DX3, which is being developed for applications in inflammatory and autoimmune diseases. It develops PAT-DX1, a small antibody fragment derived from a humanized version of the binding domain from the original mouse deoxymab antibody 3E10; and PAT-DX3 for treating primary and secondary brain cancers, and cancers and/or metastases that are associated with NETosis, or in combination with DNA damaging agents, such as radiation and other chemotherapy drugs. The company was incorporated in 2006 and is based in Nedlands, Australia.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
0.000.00%0.00
Other Institutional Investors
149.60M25.69%3.52M
Public Companies & Retail Investors
432.63M74.31%10.17M
Total
582.23M100.00%13.68M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Paralian Pty Ltd8.01%46,629,0871,096
Hevel Pty Ltd3.71%21,600,000508

FAQ

What Is the Patrys Ltd (PAB) Stock Price Today?

The Patrys Ltd stock price today is 0.0230 AUD.

What Stock Exchange Does Patrys Ltd Trade On?

Patrys Ltd is listed and trades on the Sydney Stock Exchange.

What Is the Stock Symbol for Patrys Ltd?

The stock symbol for Patrys Ltd is "PAB."

What Is the Patrys Ltd Market Cap?

As of today, Patrys Ltd market cap is 13.3900M AUD.

What Is Patrys Ltd's Earnings Per Share (TTM)?

The Patrys Ltd EPS (TTM) is -0.0083.

From a Technical Analysis Perspective, Is PAB a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Patrys Ltd Stock Split?

Patrys Ltd has split 6 times.

How Many Employees Does Patrys Ltd Have?

Patrys Ltd has 10 employees.

What is the current trading status of Patrys Ltd (PAB)?

As of Nov 18, 2026, Patrys Ltd (PAB) is trading at a price of 0.0230 AUD, with a previous close of 0.0230 AUD. The stock has fluctuated within a day range of 0.0230 AUD to 0.0230 AUD, while its 52-week range spans from 0.0200 AUD to 0.0520 AUD.

What Is Patrys Ltd (PAB) Price Target According to Analysts?

The average 12-month price target for Patrys Ltd is 0.1300 AUD, with a high estimate of 0.13 AUD and a low estimate of 0.13 AUD. 0 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +465.22% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.